Trial · NCT03446612
Registered outcomes53
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
41 to 53 of 53
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Other | Change From Baseline in Hematology Parameter of MCH | Baseline (Day 1) and at Days 42 and 59 | Blood samples were collected for the analysis of hematology parameters including MCH. Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
| Other | Absolute Values of the Hematology Parameter of Mean Corpuscular Volume (MCV) | Days 1, 42 and 59 | Blood samples were collected for the analysis of hematology parameters including MCV. |
| Other | Change From Baseline in Hematology Parameter of MCV | Baseline (Day 1) and at Days 42 and 59 | Blood samples were collected for the analysis of hematology parameters including MCV. Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
| Other | Absolute Values of Clinical Chemistry Parameters of Sodium, Potassium, Carbon-dioxide (Total), Chloride, Glucose and Urea | Days 1, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; sodium, potassium, carbon-dioxide (total), chloride, glucose and urea. |
| Other | Change From Baseline in Clinical Chemistry Parameter: Sodium, Potassium, Carbon-dioxide (Total), Chloride, Glucose and Urea | Baseline (Day 1) and at Days 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; sodium, potassium, carbon-dioxide (total), chloride, glucose and urea. Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
| Other | Absolute Values of Clinical Chemistry Parameters of Creatinine | Days 1, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; creatinine. |
| Other | Change From Baseline in Clinical Chemistry Parameter: Creatinine | Baseline (Day 1) and at Days 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; creatinine. Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
| Other | Absolute Values of Clinical Chemistry Parameters of Bilirubin (Direct/Indirect and Total) | Days 1, 14, 28, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; bilirubin (direct/indirect and total). |
| Other | Change From Baseline in Clinical Chemistry Parameter: Bilirubin (Direct/Indirect and Total) | Baseline (Day 1) and at Days 14, 28, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; creatinine and bilirubin (direct/indirect and total). Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
| Other | Absolute Values of Clinical Chemistry Parameters of Alanine Transaminase (ALT), Alkaline Phosphatase (ALP) and Aspartate Transaminase (AST) | Days 1, 14, 28, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; ALT, ALP and AST. |
| Other | Change From Baseline in Clinical Chemistry Parameter: ALT, ALP and AST | Baseline (Day 1) and at Days 14, 28, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; ALT, ALP and AST. Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
| Other | Absolute Values of Clinical Chemistry Parameters of Albumin | Days 1, 14, 28, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; Albumin. |
| Other | Change From Baseline in Clinical Chemistry Parameter: Albumin | Baseline (Day 1) and at Days 14, 28, 42 and 59 | Blood samples will be collected for the analysis of clinical chemistry parameters including; Albumin. Baseline value (Day 1) is the latest pre-dose assessment with a non-missing value, including those from unscheduled visits. Change from Baseline is defined as post-dose visit value minus Baseline value. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03446612/registered?page=3